Inactive Instrument

PDL BioPharma, Inc. Share Price

Equities

PDLI

US69329Y1047

Biotechnology & Medical Research

Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 59 01/02/09
Director of Finance/CFO - 31/12/16
Director/Board Member 72 30/09/08
Members of the board TitleAgeSince
Director/Board Member 65 10/09/17
Director/Board Member 72 30/09/08
Chief Executive Officer 59 01/02/09
More insiders
PDL BioPharma, Inc. has a portfolio of income generating assets based on alternative financings. These alternative financings fall into one of three categories: royalty monetization, debt structures and hybrids of the two. The Company's investments are typically in assets with strong intellectual property protection and are commercial stage or soon-to-be approved. The counterparties in these transactions can be biotechs, pharmas, medtech companies, universities and inventors.
More about the company